서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 6 of 6

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2016-11	Palbociclib and Letrozole in Advanced Breast Cancer Finn, Richard S.; Martin, Miguel; Rugo, Hope S.; Jones, Stephen; Im, Seock-Ah; Gelmon, Karen; Harbeck, Nadia; Lipatov, Oleg N.; Walshe, Janice M.; Moulder, Stacy; Gauthier, Eric; Lu, Dongrui R.; Randolph, Sophia; Dieras, Veronique; Slamon, Dennis J. New England Journal of Medicine, Vol.375 No.20, pp.1925-1936	DOI
2018-08	Phase III randomized study of ribociclib and fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: MONALEESA-3 Slamon, Dennis J.; Neven, Patrick; Chia, Stephen; Fasching, Peter A.; De Laurentiis, Michelino; Im, Seock-Ah; Petrakova, Katarina; Bianchi, Giulia Val; Esteva, Francisco J.; Martin, Miguel; Nusch, Arnd; Sonke, Gabe S.; De la Cruz-Merino, Luis; Beck, J. Thaddeus; Pivot, Xavier; Vidam, Gena; Wang, Yingbo; Lorenc, Karen Rodriguez; Miller, Michelle; Taran, Tetiana; Jerusalem, Guy Journal of Clinical Oncology, Vol.36 No.24, pp.2465-2472	DOI
2019-01	MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer Johnston, Stephen; Martin, Miguel; Di Leo, Angelo; Im, Seock-Ah; Awada, Ahmad; Forrester, Tammy; Frenzel, Martin; Hardebeck, Molly C.; Cox, Joanne; Barriga, Susana; Toi, Masakazu; Iwata, Hiroji; Goetz, Matthew P. npj Breast Cancer, Vol.5 No.1, p. 5	DOI
2020-02	Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer Slamon, Dennis J.; Neven, Patrick; Chia, Stephen; Fasching, Peter A.; De Laurentiis, Michelino; Im, Seock-Ah; Petrakova, Katarina; Bianchi, Giulia V.; Esteva, Francisco J.; Martin, Miguel; Nusch, Arnd; Sonke, Gabe S.; De la Cruz-Merino, Luis; Beck, J. Thaddeus; Pivot, Xavier; Sondhi, Manu; Wang, Yingbo; Chakravartty, Arunava; Rodriguez-Lorenc, Karen; Taran, Tetiana; Jerusalem, Guy New England Journal of Medicine, Vol.382 No.6, pp.514-524	DOI
2023-05	Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR+/HER2-early breast cancer Slamon, Dennis J.; Fasching, Peter A.; Hurvitz, Sara; Chia, Stephen; Crown, John; Martin, Miguel; Barrios, Carlos H.; Bardia, Aditya; Im, Seock-Ah; Yardley, Denise A.; Untch, Michael; Huang, Chiun-Sheng; Stroyakovskiy, Daniil; Xu, Binghe; Moroose, Rebecca L.; Loi, Sherene; Visco, Frances; Bee-Munteanu, Valerie; Afenjar, Karen; Fresco, Rodrigo; Taran, Tetiana; Chakravartty, Arunava; Zarate, Juan Pablo; Lteif, Agnes; Hortobagyi, Gabriel N. Therapeutic Advances in Medical Oncology, Vol.15, pp.1-16	DOI
2024-03	Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer Slamon, Dennis J.; Dieras, Veronique; Rugo, Hope S.; Harbeck, Nadia; Im, Seock-Ah; Gelmon, Karen A.; Lipatov, Oleg N.; Walshe, Janice M.; Martin, Miguel; Chavez-MacGregor, Mariana; Bananis, Eustratios; Gauthier, Eric; Lu, Dongrui R.; Kim, Sindy; Finn, Richard S. Journal of Clinical Oncology, Vol.42 No.9, pp.994-1000	DOI

1